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A	comparison	of	the	performance	of	the	
Braden	Q	and	the	Glamorgan	paediatric	
pressure	ulcer	risk	assessment	scales	in	
general	and	intensive	care	paediatric	
and	neonatal	units	
Abstract 
Aims 
To compare the predictive ability of two risk assessment scales used in children. 
Background 
There are several risk assessment scales (RASs) employed in paediatric settings but most have been 
modified from adult scales such as the Braden Q whereas the Glamorgan was an example of a scale 
designed for children.  
Methods 
Using incidence data from 513 paediatric hospital admissions, receiver operating characteristic 
(ROC) was employed to compare the two scales. The area under the curve (AUC) was the outcome of 
interest. 
Results 
The two scales were similar in this population in terms of area under the curve. Neonatal and 
paediatric intensive care were similar in terms of AUC for both scales but in general paediatric wards 
the Braden Q may be superior in predicting risk. 
Conclusion 
Either scale could be used if the predictive ability was the outcome of interest. The scales appear to 
work well with neonatal, paediatric intensive care and general children’s wards. However the 
Glamorgan scale is probably preferred by childrens’ nurses as it is easy to use and designed for use in 
children. There is some suggestion that while the two scales are similar in intensive care, for general 
paediatrics the Braden Q may be the better scale.  
Aims  
To compare the Glamorgan and Braden Q  scales in general paediatric, PICUs and NICUs.  
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Background 
Pressure ulcers affect the paediatric population, especially in those who are critically ill or with 
debilitating conditions (1). However, there is a paucity of empirical evidence upon which new 
guidelines for this area can be established (2). Children and neonates have unique characteristics, 
depending on their developmental maturity, that are different to adults, and this necessitates 
specific protocols for skin care. In order to have effective prevention and intervention procedures, 
there should be an accurate and practical assessment, hence assessment is the preliminary step 
toward suitable prevention (3, 4), however, there is little validated evidence for pressure ulcer risk 
assessments in children (2). 
Pressure ulcers in children, as in adults, have many devastating effects; such as pain, and increased 
hospital stay (3, 5). They can also cause disfigurement or permanent alopecia, which may affect the 
child’s body image (5-7). Any breaks in child’s skin by invasive medical devices, incontinence lesions, 
or other wounds may cause them to be susceptible to infection (8), and in severe cases infected 
pressure ulcers can lead to osteomyelitis (7, 9). Pressure ulcers impose a financial burden both on 
health organizations and on individual patients (5). Given the breadth of consequences on children, 
families and communities, practice aimed at pressure ulcer prevention is more favourable than 
treatment (10). 
Incidence and prevalence studies are necessary to establish benchmarking data about the size of the 
pressure ulcer problem (11, 12), and using prospective incidence studies can help in exploring the 
performance of the RASs in certain populations (13). . Most studies of prevalence and incidence are 
low quality, however when including only higher quality papers there was a prevalence (excluding 
grade I ulcers) of 0.8% (14) in paediatric populations though much higher incidence and prevalence 
figures were found in paediatric intensive care units (PICUs) than the general paediatric population. 
In a multicentre study of 412 children in 14 clinics there was a prevalence of 35%,  although these 
were mostly minor (15) there were three grade III and two grade IV pressure ulcers. A previous study 
by the same team (16) found similar results and noted that two pressure ulcers were still apparent 
after six months - the higher prevalence found in these studies are largely due to reporting of minor 
ulcers (grade I). Thus pressure ulcers occur in children, can be severe and cause serious problems. 
There are at least twelve paediatric RASs but of these only the Braden Q, Glamorgan and the 
Neonatal Risk Assessment Scale have been validated (17). 
The early development of the Braden Q scale was based on modifications to the adult Braden Risk 
assessment scale (10, 18). It was created for use in paediatric critical care, and is thought to be 
useful because of its diverse range of sub-items; items which the original authors believed to be the 
major causes of pressure ulcer development  (10). The items derived from Braden and Bergstrom’s 
conceptual model divided risk factors into two groups related to skin tolerance and to the intensity 
and duration of the pressure (19). The Braden Q Scale is composed of seven sub-items; mobility, 
activity, moisture, tissue perfusion & oxygenation, friction and shear, sensory perception, and 
nutrition. Each sub-item is scored from one to four, with four representing the lowest level of risk 
and one indicating the highest risk. The total score for any child should range from seven (the 
highest risk) to 28 (lowest risk) (10). These sub-items are the same as those found in the adult 
Braden scale, but with the addition of the seventh sub-item, ‘tissue perfusion and oxygenation’. This 
item was added to reflect the unique paediatric developmental characteristics, and to optimise the 
benefits of using data that are commonly available in PICUs. This sub-item was also included in the 
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original conceptual model used to develop the adult Braden Scale (10). The Braden Q scale has been 
tested for validity in infants and children aged from 21 days old to  eight years (11) and found to 
show good diagnostic accuracy in 3-8 year olds (20).  Validity studies have shown that children 
considered at low risk of pressure injury score an average of 25, moderate risk score an average of 
21, and high risk score an average of 16 on the Braden Q scale. In a sample of 322 PICU patients 
(pressure injury incidence 62%), the Braden Q scale, using a cut off score of 16 has demonstrated 
high sensitivity of 0.88 and moderate specificity of 0.58 (AUC 0.83, CI 0.76 – 0.91) (21). Validation 
data from the Braden Q scale authors have only sampled critically ill children in PICUs, not patients 
from general paediatric wards. No inter-rater reliability data are available for the Braden Q scale. 
The Glamorgan scale was developed using detailed data collected on 336 paediatric inpatients from 
11 hospitals in the United Kingdom, and included prevalence and incidence data. Sixty one children 
had pressure ulcers and 175 had no observed pressure ulcers. (22). A comparison of children with 
and without pressure ulcers was undertaken to determine the variables which contributed the most 
significantly to the scale.  Eleven out of the seventeen variables identified were included in the scale 
as sub-items. A reliability study was undertaken, and after additional modifications, the final scale 
included nine sub-items (23). The risk scores were adjusted so that patients with higher scores would 
be those at higher risk of developing pressure ulcers. Potential total scores can range from 0 to 42, 
with higher scores indicating a higher risk of pressure injury development (≥ 10 at risk; ≥ 15 high risk; 
≥ 20 very high risk).  The Glamorgan scale has also undergone validation in independent populations 
(24) showing in that case to be superior to the Braden Q scale.  However inter-rater reliability has 
been questioned.  In this sample there was little variability in items of the Glaorgan scale and thus while there 
was high absolute agreement there was a low intraclass correlation coefficients though the Glamorgan scale 
had higher inter-rater reliability than a visual analogue scale (25, 26). 
 
The items relating to mobility and devices or objects pressing on the skin were allocated higher 
scores than the other 7 items (22) based on expert opinion. Using a cut off score of 15, the 
Glamorgan Scale has demonstrated very high sensitivity of 0.98 and moderate specificity of 0.67 
(AUC 0.91) when tested with the data used to develop it (27). 
In summary   pressure ulcers occur in children and there is a need to assess the risk of pressure 
ulcers. Few studies have been conducted to evaluate paediatric RASs but none had considered 
neonatal intensive care units (NICUs). 
Methods 
Study design 
Prospective study 
Setting 
Paediatric inpatients in all clinical areas (Brisbane) and critical care units (Irbid) 
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Participants 
Incidence data were collected in two geographical areas using identical data collection tools. The 
areas were the King Abdullah University Hospital (KAUH) in Irbid, Jordan, and the Royal Children’s 
Hospital in Brisbane (RCHB), Australia. In KAUH data were only collected on children admitted to 
critical care areas. 	In KAUH there was one data collector (an experienced tissue viability nurse and 
PhD student), who was familiar with the Braden Q and Glamorgan scales, and the identification of 
pressure ulcers. The sample was obtained by means of consecutive non-probability sampling  (28). 
Between November 2011 and May 2012 all paediatric patients who were admitted to the critical 
care units, and who were eligible to participate (no pre-existing pressure ulcers, and parental 
consent), were recruited, to obtain a target sample size of over 200 individuals. The critical care 
areas were PICUs, NICUs, and general intermediate care (GIMU, though only one child was recruited 
from GIMU). 
In KAUH participants had a stay of over 72 hours so that at least one follow-up skin assessment could 
be carried out after the initial assessment. Pressure ulcer risk assessments using both the Glamorgan 
and the Braden Q tools were performed three times a week (every 2 to 3 days) for the first two 
weeks of admission, then once a week until participants were discharged, died, or the study period 
ended.  
In Brisbane, data were collected on children in all clinical areas. Data collection commenced early in 
2010 to include all children admitted to the hospital with no pre-existing pressure ulcers, to obtain a 
sample of over 300 complete data sets. All children aged less than 18 years were included. Education 
was given to clinical nursing staff working in in-patient areas regarding the use of both the Braden Q 
(previously used in the clinical area) and Glamorgan scales tools. Further education was provided 
where gaps in knowledge and practice were identified. The education provided: 
• Theoretical information on paediatric pressure injuries and the risk assessment tools. 
• Feedback to in-patient areas on their uptake of the pressure ulcer risk assessment tools.  
• A discussion forum for nurses to communicate their concerns about pressure injury risk 
management. 
• In both areas, participants had skin and pressure ulcer risk assessments (using both the 
Glamorgan and Braden Q tools) within 24 hours of admission. Only individuals with no pre-
existing skin damage were included in the sample. 
 
In RCHB the data collection phase commenced one month after rolling out the Glamorgan and 
Braden Q scales. Data were collected on all paediatric inpatients that had a length of stay of two 
nights or more. The data were collected as part of normal patient care and clinical assessment. 
Variables 
Nurses were asked to collect pressure injury risk assessments on each child using both the Braden Q 
and Glamorgan scales on a daily basis. Data collection sheets were collated by ward reception staff 
and collected weekly by the Project Officer. 
 The EUPAP & NPUAP  (29) pressure ulcer categorisation scale was used at both sites. 
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Bias 
By including all patients in the relevant areas (Brisbane) and from whom consent was obtained 
(Irbid) any selection bias was reduced. 
Study size 
212 paediatric admissions in KAUH, and on 301 paediatric admissions at RCHB 
Statistical methods 
ROC analysis was used to compute the AUC for the two scales. An AUC value significantly greater 
than 0.5 indicates the scale is performing better than randomly and the AUC provides a comparative 
value for the RASs under consideration. 
Ethical considerations 
Research Ethics committee approval was obtained for the studies in both areas. Information about 
the projects was given to parents and young people (where appropriate) prior to obtaining consent 
in Jordan (in Brisbane consent was waivered) to participate. 
Results 
Participants  
Data were collected on 212 paediatric admissions in KAUH, and on 301 paediatric admissions at 
RCHB.  
Descriptive data 
The sample size, gender, proportion of critical care (PICU, NICU and GIMU) and pressure ulcers are 
shown in Table 1. 
Table 1 
 Sample 
size 
Male 
gender 
Critical care 
admissions 
Developed one or more pressure 
ulcers 
KAUH 212 124 (59%) 212 (100%) 19 (9%) 
RCHB 301 150 (49%) 50 (16%) 16 (5%) 
Total 513 274 (53%) 263 (51%) 35 (7%) 
 
Most pressure ulcers were category I or II (Table 2) according to the EPUAP and NPUAP (29) 
descriptors. The category III ulcers identified in the KAUH sample were found on the occiput (two 
ulcers), and heel (one ulcer).  Twelve children in this sample had device-related ulcers. 
 
Table 2.  
 Pressure ulcer 
incidence 
Total number of pressure 
ulcers (in number of 
children) 
Category I 
(in number of 
children) 
Category 
II 
(in number of 
Category 
III 
(in number of 
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children) children) 
KAUH 9% 
(n=19) 
29 (19) 12 (8) 
 
14 (8) 
 
3 (3) 
 
RBCH 5% 
(n=16) 
25 (16)  19 (10) 5 (5) 1(1) 
Total 6.8% 
(n=35) 
54 (35) 31 (18) 
 
19 (13) 
 
4 (4) 
 
Main results 
The AUC (see Figure 1 and Table 3) was higher for Braden Q than Glamorgan but the 95% confidence 
intervals overlapped considerably so it is not likely that there is a statistically significant difference 
between the two AUCs. 
Figure 1. ROC curve for the Glamorgan and Braden Q scales 
 
 
Table 3 AUC all children 
 Area P value 95% Confidence Interval 
Glamorgan score 0.748 <0.001 0.673, 0.822 
Braden Q score 0.820 <0.001 0.760, 0.880 
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Focussing on specific clinical areas,  the two scales were virtually identical with respect to 
AUC in intensive care but for general paediatrics the Braden Q performed better (see Table 
4). Unfortunately the numbers are small to start with (35 patients with ulcers) and drop 
further when broken down by specialty (11 for PICU, 15 for NICU and only 9 for general 
paediatrics). 
 
 
Table 4 AUC for PICU, NICU and general paediatrics 
  Area P value 95% Confidence Interval 
PICU (n=93) Glamorgan score 0.76 0.006 0.61, 0.91 
 Braden Q score 0.74 0.010 0.58, 0.90 
NICU (n=169) Glamorgan score 0.82 <0.001 0.73, 0.91 
 Braden Q score 0.82 <0.001 0.73, 0.92 
General (n=251) Glamorgan score 0.57 0.478 0.37,0.77  
 Braden Q score 0.83 <0.001 0.73,0.92 
 
Finally as grade I ulcers are considered less serious, an analysis of grades II/III (there were no grade 
IV ulcers) showed very similar results with the Braden Q higher but again having overlapping 
confidence intervals (see Table 5).  
Table 5 AUC Excluding grade I ulcers 
 Area P value 95% Confidence Interval 
Glamorgan score 0.77 <0.001 0.67, 0.87 
Braden Q score 0.85 <0.001 0.77, 0.93 
 
Finally AUCs were computed for each site, see Table 6. The broadly similar AUCs (though with wide 
Cis) suggest it was appropriate to pool data. 
  
Table 6 AUC by site 
  Area P value 95% 
Confidence 
Interval 
Brisbane Glamorgan total score .676 0.018 0.53, 0.82 
Braden total score .827 <0.001 0.74, 0.91 
Irbid Glamorgan total score .788 <0.001 0.71, 0.87 
Braden total score .801 <0.001 0.72, 0.89 
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Discussion 
The incidence of pressure ulcers in this study is higher than the figure given by Kottner et al for 
general paediatric units and lower than Schluer et al’s figures for PICUs.  Given this dataset is from 
both settings the incidence is thus in line with previous studies. This is a large dataset from general 
paediatric wards, PICUs and NICUs. There are few studies identified that focus on NICUs though the 
Neonatal Skin Risk Assessment Scale (NSRAS) has been shown to be reliable and have predictive 
power  (30, 31).  This study demonstrates that it is acceptable to use the Braden Q or the Glamorgan 
scale for this population. Similarly both scales appear to work similarly on a PICU sample. For general 
paediatric units in this sample the Braden Q appeared superior. 
Historically, the Children’s Health Service in Brisbane (RBCH) has used the Braden Q scale for 
pressure injury risk assessment. The service has found poor compliance with the Braden Q scale 
across acute care areas. The complexity of the Braden Q scale has been given as a reason for its low 
level of compliance, use and acceptability according to feedback to the authors from clinicians. The 
Glamorgan scale has been positively received in Scotland (where it has been included in the Scottish 
National toolkit), Northern Ireland (where it has been implemented as the scale to be used across 
the province), the Republic of Ireland, Wales England, Germany, Spain, New Zealand, England, and 
Australia. Since the Glamorgan scale is thought by paediatric nurses to be more suitable and easier 
to use than Braden Q it probably should be the first choice for PICUs and NICUs. While Braden Q may 
be a better scale in general paediatrics it is premature to make such a claim on one study with few 
cases. It is also questionable whether two different scales should be in use in the same hospital 
where both PICU and NICU exist.  
There have been few studies comparing paediatric RASs. Most studies are concerned with predictive 
validity and/or inter-rater reliability of one scale. Figures on different RASs used in different 
populations are not comparable. There is one other study comparing the Braden Q and Glamorgan 
(24) which showed the Glamorgan superior to Braden Q while this study does not support this result. 
Of the many other paediatric RASs the most widely validated is the NSRAS and thus probably one of 
these three RASs should be considered for implementation in the absence of further studies. 
Testing the available paediatric pressure ulcer RASs  can give an indication of their predictive ability 
(validity), however, there in adults  no study has shown using even a valid and reliable risk 
assessment tool  reduces the pressure ulcer incidence rate in clinical practice (32, 33). However even 
if they do not reduce incidence of pressure ulcers (and the work has not been done in children so we 
have no idea if they do or not) they are useful for audit and research purposes. They are useful for 
audit since they show the number of patients who are high, medium and low risk which might be 
useful information to (say) adjust staffing levels. They could be used in cases where hospitals are 
sued over pressure ulcers to show whether the patient was high risk and what was done about it if 
so. They have been used in research to (e.g.) match patients at various risk levels who either do or 
do not have pressure ulcers and then consider (e.g.) lengths of stay (34). 
Strengths and limitations 
This is the first study to consider NICU (n=169) patients employing these two scales. The sample size 
is large (n=513) but as pressure ulcers are relatively uncommon in children the number of ulcers is 
small (n=35 children with ulcers) and the number of more serious ulcers smaller (n=16). The results 
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from the overall sample are probably robust but splitting analyses into the three clinical areas may 
give results that are not generalizable especially for general paediatrics where the number of ulcers 
was in single figures. The numbers with serious ulcers is too small to effect a sub-analysis by clinical 
area. The small numbers of pressure ulcers potentially may make the model unstable as generally it 
is advised to have ten subjects  
Using both scales at the same time by identical raters may contaminate both scorings. As with all 
similar studies, clinical staff may have instituted preventive measures on high risk children which 
would have the effect of reducing the sensitivity of the scales.  This problem has been discussed in 
DeFloor & Grypdonck (35) who state in many studies the preventive measure are not described or 
categorised as standard care. However as this is true for both scales a comparison between them is 
valid and it would be unethical not to conduct a comparison study.  
Conclusion 
The Braden Q and Glamorgan scales probably have similar validity in paediatric critical care areas 
and for more serious pressure ulcers. The Braden Q may be a better scale in general paediatric 
wards but with such a small number of ulcers in this group it is premature to draw a firm conclusion 
on this.  
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Highlights 
There are several risk paediatric pressure ulcer risk assessment scales  
The Glamorgan and Braden Q scales appear to work well with neonatal, paediatric 
intensive care and general children’s wards 
There is some evidence Braden Q may be better in general paediatrics 
